Clrb stock price target
WebView CLRB revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $20.00: Low: $7.00: Average: $13.25: Current Price: $1.3900: CLRB will ... WebApr 14, 2024 · KeyCorp upped their target price on shares of West Pharmaceutical Services from $315.00 to $375.00 and gave the stock an “overweight” rating in a report on Friday, February 17th.
Clrb stock price target
Did you know?
WebApr 14, 2024 · The firm set a “sell” rating on the biopharmaceutical company’s stock. Cellectar Biosciences Price Performance. Shares of NASDAQ:CLRB opened at $1.38 on Friday. The company has a market ... Web19 hours ago · The stock price has decreased by -77.07% in the last 52 weeks. The beta is 1.17, so CLRB's price volatility has been higher than the market average. Beta (1Y)
WebApr 14, 2024 · XPER stock opened at $10.00 on Friday. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.11. Xperi has a 12-month low of $8.15 and a 12-month high of ... WebPrice Target. Based on short-term price targets offered by four analysts, the average price target for Cellectar Biosciences, Inc. comes to $13.25. The forecasts range from a low of …
WebJul 21, 2024 · InvestorsObserver is giving Cellectar Biosciences Inc (CLRB) an Analyst Rating Rank of 75, meaning CLRB is ranked higher by analysts than 75% of stocks. The average price target for CLRB is $5.9 and analyst’s rate the stock as a Strong Buy. WebApr 12, 2024 · According to analysts' consensus price target of $6.00, Ardelyx has a forecasted upside of 36.4% from its current price of $4.40. Amount of Analyst Coverage Ardelyx has only been the subject of 1 research reports in the past 90 days. See Top Rated MarketRank™ Stocks Here Sponsored Advertiser Disclosure
WebApr 12, 2024 · Cellectar Biosciences has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, Carisma Therapeutics has a beta of 0.74, meaning that its stock price ...
WebVislink Technologies, Inc. (VISL) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed Dow Futures Nasdaq Futures +13.00 Russell 2000 Futures Crude Oil Vislink... drowned abyss marblesWebCellectar Biosciences (CLRB) Stock Price & Analysis Follow 1,137Followers Portfolio CLRB Stock Chart & Stats Advanced Chart > 1d5d3m6mYTD1y3y5y Day’s Range$0 - $0 52-Week Range$1.25 - $7.90 Previous Close$1.56 Volume175.78K Average Volume (3M)72.39K Market Cap$14.64M Enterprise Value-$1.56M Total Cash (Recent … collective name for spidersWebJul 20, 2024 · The consensus price target as assigned by Wall Street analysts is $6.23, which translates to bulls needing to increase their stock price by 83.15% from its current value. Analyst projections state that CLRB is forecast to be at a … drowned abyss diceWebFind real-time PLX - Protalix Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. drowned abyss lost marbleWebAlzamend Neuro Stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for ALZN in the last 3 months. Top Stocks. ... The average price target is $6.75 with a high forecast of $6.75 and a low forecast of $6.75. drowned 1 hourWebCellectar BioSciences Price Targets What analysts think CLRB stock price will be. Current Price $1.38 Target Price $14.75 968.9% Upside $1 $16 Cellectar BioSciences Stock Rating What analysts recommend for CLRB stock, on a scale from 1 (buy) to 5 (sell). Strong Buy Strong Buy 100% Buy 0% Hold 0% Sell 0% Strong Sell 0% collective name given to charles ii ministersWeb1 day ago · According to 10 analysts, the average rating for CLRB stock is "Buy." The 12-month stock price forecast is $13.52, which is an increase of 879.71% from the latest … collective name for starlings